55 related articles for article (PubMed ID: 17518636)
1. Engineering of biologically active living heart valve leaflets using human umbilical cord-derived progenitor cells.
Schmidt D; Mol A; Odermatt B; Neuenschwander S; Breymann C; Gössi M; Genoni M; Zund G; Hoerstrup SP
Tissue Eng; 2006 Nov; 12(11):3223-32. PubMed ID: 17518636
[TBL] [Abstract][Full Text] [Related]
2. Stem cells in the umbilical cord.
Weiss ML; Troyer DL
Stem Cell Rev; 2006; 2(2):155-62. PubMed ID: 17237554
[TBL] [Abstract][Full Text] [Related]
3. Strategies for Development of Synthetic Heart Valve Tissue Engineering Scaffolds.
Snyder Y; Jana S
Prog Mater Sci; 2023 Oct; 139():. PubMed ID: 37981978
[TBL] [Abstract][Full Text] [Related]
4. Serum- and xeno-free culture of human umbilical cord perivascular cells for pediatric heart valve tissue engineering.
Parvin Nejad S; Lecce M; Mirani B; Machado Siqueira N; Mirzaei Z; Santerre JP; Davies JE; Simmons CA
Stem Cell Res Ther; 2023 Apr; 14(1):96. PubMed ID: 37076906
[TBL] [Abstract][Full Text] [Related]
5. Biomaterials in Valvular Heart Diseases.
Taghizadeh B; Ghavami L; Derakhshankhah H; Zangene E; Razmi M; Jaymand M; Zarrintaj P; Zarghami N; Jaafari MR; Moallem Shahri M; Moghaddasian A; Tayebi L; Izadi Z
Front Bioeng Biotechnol; 2020; 8():529244. PubMed ID: 33425862
[TBL] [Abstract][Full Text] [Related]
6. Which Biological Properties of Heart Valves Are Relevant to Tissue Engineering?
Chester AH; Grande-Allen KJ
Front Cardiovasc Med; 2020; 7():63. PubMed ID: 32373630
[TBL] [Abstract][Full Text] [Related]
7. Cell Sources for Tissue Engineering Strategies to Treat Calcific Valve Disease.
Jover E; Fagnano M; Angelini G; Madeddu P
Front Cardiovasc Med; 2018; 5():155. PubMed ID: 30460245
[TBL] [Abstract][Full Text] [Related]
8. A Comparative Study of Rat Lung Decellularization by Chemical Detergents for Lung Tissue Engineering.
Tebyanian H; Karami A; Motavallian E; Aslani J; Samadikuchaksaraei A; Arjmand B; Nourani MR
Open Access Maced J Med Sci; 2017 Dec; 5(7):859-865. PubMed ID: 29362610
[TBL] [Abstract][Full Text] [Related]
9. Application of hydrogels in heart valve tissue engineering.
Zhang X; Xu B; Puperi DS; Wu Y; West JL; Grande-Allen KJ
J Long Term Eff Med Implants; 2015; 25(1-2):105-34. PubMed ID: 25955010
[TBL] [Abstract][Full Text] [Related]
10. Fetal umbilical vein transplantation for the repair of middle cerebral artery injury.
Hou X; Yuan Y; Yin J; Yang S; Xie L; Wang S
Neural Regen Res; 2013 Dec; 8(34):3249-54. PubMed ID: 25206646
[TBL] [Abstract][Full Text] [Related]
11. Viscoelastic evaluation of fetal umbilical vein for reconstruction of middle cerebral artery.
Li D; Xu D; Li P; Wei J; Yang K; Zhao C
Neural Regen Res; 2013 Nov; 8(32):3055-62. PubMed ID: 25206626
[TBL] [Abstract][Full Text] [Related]
12. Effects of lentiviral infection of mesenchymal stem cells on the expression of octamer transcription factor 4.
Chang J; Tang L; Lei H; Zhang XG; Zuo Z; Huang W; Fu H
Mol Med Rep; 2014 Nov; 10(5):2249-54. PubMed ID: 25174942
[TBL] [Abstract][Full Text] [Related]
13. Human umbilical cord-derived mesenchymal stem cells differentiate into epidermal-like cells using a novel co-culture technique.
Li D; Chai J; Shen C; Han Y; Sun T
Cytotechnology; 2014 Aug; 66(4):699-708. PubMed ID: 24952026
[TBL] [Abstract][Full Text] [Related]
14. Mesenchymal stem or stromal cells from amnion and umbilical cord tissue and their potential for clinical applications.
Lindenmair A; Hatlapatka T; Kollwig G; Hennerbichler S; Gabriel C; Wolbank S; Redl H; Kasper C
Cells; 2012 Nov; 1(4):1061-88. PubMed ID: 24710543
[TBL] [Abstract][Full Text] [Related]
15. The rationale behind collecting umbilical cord blood.
Zech NH; Broer N; Ribitsch I; Zech MH; Broer KH; Ertan K; Preisegger KH
J Turk Ger Gynecol Assoc; 2010; 11(2):99-101. PubMed ID: 24591908
[TBL] [Abstract][Full Text] [Related]
16. Three-dimensional printed trileaflet valve conduits using biological hydrogels and human valve interstitial cells.
Duan B; Kapetanovic E; Hockaday LA; Butcher JT
Acta Biomater; 2014 May; 10(5):1836-46. PubMed ID: 24334142
[TBL] [Abstract][Full Text] [Related]
17. New technologies for surgery of the congenital cardiac defect.
Kalfa D; Bacha E
Rambam Maimonides Med J; 2013 Jul; 4(3):e0019. PubMed ID: 23908869
[TBL] [Abstract][Full Text] [Related]
18. Isolation method and xeno-free culture conditions influence multipotent differentiation capacity of human Wharton's jelly-derived mesenchymal stem cells.
Corotchi MC; Popa MA; Remes A; Sima LE; Gussi I; Lupu Plesu M
Stem Cell Res Ther; 2013 Jul; 4(4):81. PubMed ID: 23845279
[TBL] [Abstract][Full Text] [Related]
19. Tissue engineered aortic valve.
Dohmen PM
HSR Proc Intensive Care Cardiovasc Anesth; 2012; 4(2):89-93. PubMed ID: 23440902
[TBL] [Abstract][Full Text] [Related]
20. Tissue engineering on matrix: future of autologous tissue replacement.
Weber B; Emmert MY; Schoenauer R; Brokopp C; Baumgartner L; Hoerstrup SP
Semin Immunopathol; 2011 May; 33(3):307-15. PubMed ID: 21279358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
